The New York State Psychiatric Institute
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1895-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.nyspi.org
Open Trial of Family-Based Treatment for Anorexia Nervosa
Not Applicable
Completed
- Conditions
- Anorexia Nervosa
- Interventions
- Behavioral: Family-Based Treatment
- First Posted Date
- 2007-01-01
- Last Posted Date
- 2013-09-26
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 20
- Registration Number
- NCT00417521
Dichotic Listening as a Predictor of Medication Response in Depression
Phase 4
Completed
- Conditions
- Major Depressive DisorderDysthymia
- Interventions
- First Posted Date
- 2006-11-29
- Last Posted Date
- 2018-04-30
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 17
- Registration Number
- NCT00404755
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana
Phase 2
Completed
- Conditions
- Marijuana Use
- Interventions
- First Posted Date
- 2006-11-23
- Last Posted Date
- 2018-03-15
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 49
- Registration Number
- NCT00403117
Interpersonal Psychotherapy for Depressed Adolescents Engaging in Non-suicidal Self-injury
Phase 1
Completed
- Conditions
- DepressionSelf-injurious Behavior
- Interventions
- Behavioral: Interpersonal Psychotherapy for Depressed Adolescents
- First Posted Date
- 2006-11-17
- Last Posted Date
- 2013-01-28
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 10
- Registration Number
- NCT00401102
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-compulsive Disorder
Not Applicable
Completed
- Conditions
- Obsessive-Compulsive Disorder
- Interventions
- First Posted Date
- 2006-10-18
- Last Posted Date
- 2014-04-25
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 100
- Registration Number
- NCT00389493
- Locations
- 🇺🇸
University of Pennsylvania Center for the Treatment and Study of Anxiety, Philadelphia, Pennsylvania, United States
🇺🇸New York State Psychiatric Institute, New York, New York, United States
Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence
Not Applicable
Completed
- Conditions
- Cocaine Dependence
- Interventions
- Behavioral: Community Reinforcement Approach
- First Posted Date
- 2006-09-15
- Last Posted Date
- 2016-07-01
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 50
- Registration Number
- NCT00376558
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Effect of Baclofen on Marijuana Withdrawal and Relapse
Phase 2
Completed
- Conditions
- Marijuana Dependence
- Interventions
- First Posted Date
- 2006-09-08
- Last Posted Date
- 2017-05-10
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 13
- Registration Number
- NCT00373295
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Effects of Aripiprazole on Cocaine Craving and Self-Administration
Phase 2
Completed
- Conditions
- Cocaine Abuse
- Interventions
- First Posted Date
- 2006-09-08
- Last Posted Date
- 2017-09-11
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 26
- Registration Number
- NCT00373880
- Locations
- 🇺🇸
Irving Center for Clinical Research, New York, New York, United States
Effects of Smoked Marijuana on Risk Taking and Decision Making Tasks
Phase 1
Completed
- Conditions
- Marijuana Use Disorder
- Interventions
- Drug: Low THC marijuana (1.8 %THC)Drug: High THC marijuana (3.9% THC)
- First Posted Date
- 2006-09-08
- Last Posted Date
- 2018-12-19
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 36
- Registration Number
- NCT00373399
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse
Phase 2
Completed
- Conditions
- Marijuana Dependence
- Interventions
- First Posted Date
- 2006-09-08
- Last Posted Date
- 2013-02-05
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 8
- Registration Number
- NCT00373503
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath